Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Pfizer, Foot Locker Rise Premarket; Gilead Falls

Published 20/11/2020, 13:08
Updated 20/11/2020, 13:09
© Reuters.

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Friday, November 20th. Please refresh for updates.

  • Pfizer (NYSE:PFE) stock rose 1.9% after the pharma giant said it would apply to the FDA later Friday for official usage of its Covid-19 vaccine, and would be poised to send out doses very quickly after receiving that approval.

  • Ross Stores (NASDAQ:ROST) stock rose 4.4% after the off-price retailer reported a much better-than-expected third quarter, although the company was cautious about its outlook.

  • FireEye (NASDAQ:FEYE) stock soared 13% after the cyber-security company said it will receive a $400 million investment from private equity firm Blackstone (NYSE:BX) and venture capital firm ClearSky.

  • Gilead (NASDAQ:GILD) stock fell 1.2% after the World Health Organisation recommended against the use of remdesivir, Gilead’s antiviral drug, for Covid-19, after concluding that there isn’t evidence that the drug reduces deaths or recovery times.

  • Williams-Sonoma (NYSE:WSM) stock rose 7.6% after the home furnishings retailer posted a big earnings beat, with its digital sales jumping 49% year over year.

  • Foot Locker (NYSE:FL) stock rose 2.9% after the retailer posted better than expected earnings for the latest quarter, helped by same-store sales rising by 7.7%.

  • Workday (NASDAQ:WDAY) stock fell 3.6% despite the software company beating estimates with its quarterly results. It also issued warnings about the lingering impact of the pandemic on its results.

  • Hibbett Sports (NASDAQ:HIBB) stock rose 5.1% after its quarterly earnings soundly beat expectations, helped by a same-store sales increase of 21%.

  • Capri Holdings (NYSE:CPRI) stock rose 4.6% after investment bank BTIG upgraded its investment stance to “buy” from “neutral”, citing the current valuation level.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.